Have Fun if you haven’t done this already! Just a suggestion, but look into ILD & pulmonary fibrosis/community acquired pneumonia & the COVID trials. It’s interesting & to have REMAP-CAP & another major Investigator wanting to trial DMX-200 for ARDS/COVID is pretty interesting, as it’s an anti-inflammatory & antifibrotic drug.
I know a lot of companies on the ASX jumped on the COVID bandwagon, but this was legit. There were drugs like Colchicine trialled in ARDS that work really well in acute cardiac inflammation as well, so there was reason to look into this. NSAIDS can sometimes not be great, and steroids, well there is criteria for that. MAbs & Antibiotics also.
Did you also know it’s been trialled in cancer patients? I believe that this is outside of our patents though, as is Hep B use in Asia.
Your eyes will be sore by this afternoon Ma. Have a good day.
Have Fun if you haven’t done this already! Just a suggestion,...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $191.0M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.8¢ | 34.5¢ | $580.1K | 1.647M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 156698 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 57957 | 3 |
View Market Depth
| Last trade - 10.53am 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.5¢ |
Change
-0.005 ( 0.83 %) |
||||
| Open | High | Low | Volume | ||
| 35.5¢ | 35.5¢ | 34.0¢ | 656065 | ||
| Last updated 11.13am 07/05/2024 ? | |||||
| DXB (ASX) Chart |